METTL3- and METTL16-mediated m6A modification stabilizes ZNNT1 in HCC, which enhances macrophage recruitment and polarization to M2 via the osteopontin (OPN)/S100A9 feedback loop, ultimately supporting immune evasion and tumor progression (49). Here, METTL3 is linked to neoplasm.